Clinical trials
Infection, Hospital clinical trials
Below are recruiting infection, hospital clinical trials, each written for real people, not researchers. We’re tracking 398 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06919068Recruiting
Colon camera capsule for gut bacteria in the blood
This trial tests whether a camera capsule can detect problems in the large intestine when certain gut bacteria are found in the blood. If you have one of these bacteria and are stable enough for the exam, it might help identify the source of the infection.
OdenseAges 18 years+ - NCT07137247Recruiting
How the immune system changes over time in chronic hepatitis B
This study tracks how the immune system works in people with chronic hepatitis B who haven't taken antiviral medication in the last 6 months. It aims to understand the natural history of the infection without treatment.
Guangzhou, GuangdongAges 1–80 - NCT06808451Recruiting
Comparing DNA test vs. standard culture for UTI diagnosis
This study compares two ways to diagnose urinary tract infections: a newer DNA test (PCR) versus the standard urine culture. The goal is to see if the DNA test finds infections faster and more accurately, so you can get the right treatment sooner.
Cleveland, OhioAges 18 years+ - NCT05329883Recruiting
Testing infection risk after urinary stent removal
This study looks at urinary tract infections that can happen after a stent is removed. It will compare approaches around stent removal to see how to lower the chance of infection afterward.
Ghent, Eastern-FlandersAges 18 years+ - NCT06052033Recruiting
Light therapy vs. laser for persistent cervical changes with HPV
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
Wenzhou, ZhejiangAges 18–65 - NCT06467864Recruiting
Predicting lung infection outcomes using early bacteria tests
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
Nanjing, JiangsuAges 18 years+ - NCT07292857Recruiting
Respiratory infection risk in postmenopausal women on HRT or not
This study looks at how the risk of respiratory infections (like colds or flu) may differ in postmenopausal women who use hormone replacement therapy (HRT) and those who do not. You will wear a smartwatch for six months and track your health through a smartphone app.
BernAges 40–60 - NCT06603961Recruiting
Preventing leg swelling after bypass surgery with a special bandage
This trial tests a custom pressure-guided elastic bandage to prevent leg swelling after coronary artery bypass surgery. The bandage is wrapped around the leg where a vein was taken for the bypass.
Bangkok, Bangkok NoiAges 18 years+ - NCT04320732Recruiting
Study COVID-19 spread at home and work
This study looks at what factors make COVID-19 spread more easily in the community and workplace. It may help researchers understand how to reduce transmission in everyday settings.
OsloAges 18 years+ - NCT02454569Recruiting
Study for people living with HIV willing to join
This study follows people who have tested positive for HIV. It aims to better understand HIV over time, but you can only participate if you agree to join the study.
Battalapalli, Andhra PradeshAges Any age - NCT07763054Recruiting
Low-dose antifungal prevention for patients with low white blood cell counts
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent fungal infections in patients whose white blood cell counts are very low for more than a week. It may help patients who are at high risk for fungal infections and cannot take other antifungal drugs.
Hainan, HainanAges 18–75 - NCT06749483Recruiting
Gut bacteria and infection in intensive care patients
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
Jena, ThuringiaAges 18 years+ - NCT05257538Recruiting
Stool transplant to treat early C. difficile infection
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
TurkuAges 18–120 - NCT04028401RecruitingPhase 3
Skin prep study to reduce bacteria in shoulder replacement surgery
This study tests whether a specific skin-cleaning method before shoulder replacement surgery can reduce a common bacteria (Cutibacterium acnes) found on skin and deeper samples. It may help lower the risk of infection or contamination during prosthetic shoulder surgery.
AngersAges 18 years+ - NCT05491434Recruiting
Study of muscle loss in colon cancer patients
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
L'Hospitalet de Llobregat, BarcelonaAges 70 years+ - NCT05958290Recruiting
Lifelong antibiotics versus stopping antibiotics after device infection
This trial studies whether people with an implanted heart device infection should take antibiotics for life or stop antibiotics and monitor closely. It is for situations where doctors think removing the device is not a safe or suitable option.
Copenhagen, Capital RegionAges Any age - NCT07130799Recruiting
Monitoring immune response in severe abdominal infections with fungal risk
This trial monitors a marker of immune function (monocyte HLA-DR) in patients with severe abdominal infections that may lead to fungal infections. It aims to see if this marker can help guide treatment.
Vandœuvre-lès-NancyAges 18 years+ - NCT02271243Recruiting
Find the source of bloodstream infections from central line germs
This study uses special genetic testing of bacteria from blood to figure out where central-line bloodstream infections come from. Results may help doctors better identify the source and improve prevention and treatment.
Boston, MassachusettsAges Any age - NCT07756554Recruiting
Care at the nursing home instead of hospital
This trial tests whether treating nursing home residents at their nursing home, instead of sending them to the hospital, is a good alternative. It aims to see if this approach can improve care and avoid unnecessary hospital visits.
CopenhagenAges 18 years+ - NCT06900829Recruiting
HIV testing program for European hospitals
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
GhentAges 18 years+ - NCT07847346Recruiting
Study of blood vessel and graft infections in China
This study collects information from people who have or might have infections in their blood vessels or in artificial tubes (grafts) placed in their blood vessels. The study will look at how these infections are treated and what outcomes patients have, to help improve future care.
ShanghaiAges 18 years+ - NCT06976125Recruiting
Using a model to guide antibiotic choice for UTI after ER visit
This trial tests whether a prediction model can help doctors choose the right antibiotic for women with a urinary tract infection (UTI) after an emergency room visit. It aims to improve treatment and reduce unnecessary antibiotics.
Cleveland, OhioAges 18 years+ - NCT07313865Recruiting
Blood infection study to understand heart valve infections
This study collects blood samples and medical information from patients with certain bloodstream infections to better understand why some develop a heart valve infection. The goal is to find out why some people get this complication and how to predict it.
Clermont-Ferrand, FranceAges 18 years+ - NCT04722029RecruitingPhase 1/Phase 2
Donor immune-cell therapy for stubborn adenovirus infections
This study tests whether specially matched donor T-cells can control “refractory” adenovirus (a virus) that isn’t responding to usual antiviral medicines. It may help if the infection keeps coming back or is already affecting organs like the lungs or bowel.
Columbus, OhioAges Up to 60 years
Hear when a new Infection, Hospital trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infection, hospital?
- Yes. Clin2 currently lists 398 recruiting infection, hospital studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infection, hospital trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infection, hospital trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.